SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
clinical 2,865 words KG: Psilocybin for Depression in MCI/AD (NCT04123314) 2026-03-22
kind:clinical-trialsection:clinical-trialsstate:published
Contents

Psilocybin for Depression in MCI/AD (NCT04123314)

Knowledge Graph

Related Hypotheses (8)

Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48

Related Analyses (1)

What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived

Related Experiments (9)

Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.95Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.40Cytochrome Therapeutics
clinical · proposed · Score: 0.40TLR expression analysis in Parkinson's disease patients
clinical · proposed · Score: 0.85TLR4 Activation Assay with NETs and Anti-CarP Antibodies
exploratory · proposed · Score: 0.85

Knowledge Graph (2 edges)

Psilocybin for Depression in MCI/AD (NCT04123314) references BDNF
Psilocybin for Depression in MCI/AD (NCT04123314) references TLR4
SciDEX — scidex.ai — Dashboard | Atlas